Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Philippe Mathurin

Showing results (211-220 of 286) with videos related to

Pageof 29
Sort By:
Alcoholism, Clinical and Experimental Research|April 16, 2015
Brief report: genetics of alcoholic cirrhosis-GenomALC multinational studyJohn B Whitfield, Khairunnessa Rahman, Paul S Haber, et al.
Alimentary Pharmacology & Therapeutics|February 2, 2024
Meta-analysis: Prevalence and impact of alcohol abstinence in alcohol-associated cirrhosisWen Hui Lim, Phoebe Tay, Cheng Han Ng, et al.
Journal of Hepatology|June 25, 2017
Liver transplantation in the most severely ill cirrhotic patients: A multicenter study in acute-on-chronic liver failure grade 3Florent Artru, Alexandre Louvet, Isaac Ruiz, et al.
Hepatology (Baltimore, Md.)|February 20, 2024
Serum aryl hydrocarbon receptor activity is associated with survival in patients with alcohol-associated hepatitisTomoo Yamazaki, Tetsuya Kouno, Cynthia L Hsu, et al.
Clinical and Molecular Hepatology|January 9, 2025
Global epidemiology of alcohol-related liver disease, liver cancer, and alcohol use disorder, 2000-2021Pojsakorn Danpanichkul, Luis Antonio Díaz, Kanokphong Suparan, et al.
Nature Communications|July 28, 2021
Super enhancer regulation of cytokine-induced chemokine production in alcoholic hepatitisMengfei Liu, Sheng Cao, Li He, et al.
JHEP Reports : Innovation in Hepatology|March 20, 2023
TACE and conformal radiotherapy <i>vs</i>. TACE alone for hepatocellular carcinoma: A randomised controlled trialCyrille Féray, Loic Campion, Philippe Mathurin, et al.
Journal of Hepatology|March 15, 2012
Rapid and strong antiviral activity of the non-nucleosidic NS5B polymerase inhibitor BI 207127 in combination with peginterferon alfa 2a and ribavirinDominique Larrey, Ansgar W Lohse, Victor de Ledinghen, et al.
Hepatology (Baltimore, Md.)|June 23, 2019
Intestinal Fungal Dysbiosis and Systemic Immune Response to Fungi in Patients With Alcoholic HepatitisSonja Lang, Yi Duan, Jinyuan Liu, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|August 28, 2013
Brivanib in patients with advanced hepatocellular carcinoma who were intolerant to sorafenib or for whom sorafenib failed: results from the randomized phase III BRISK-PS studyJosep M Llovet, Thomas Decaens, Jean-Luc Raoul, et al.
Pageof 29

Showing results (211-220 of 286) with videos related to

Sort By:
Pageof 29
Alcoholism, Clinical and Experimental Research|April 16, 2015
Brief report: genetics of alcoholic cirrhosis-GenomALC multinational studyJohn B Whitfield, Khairunnessa Rahman, Paul S Haber, et al.
Alimentary Pharmacology & Therapeutics|February 2, 2024
Meta-analysis: Prevalence and impact of alcohol abstinence in alcohol-associated cirrhosisWen Hui Lim, Phoebe Tay, Cheng Han Ng, et al.
Journal of Hepatology|June 25, 2017
Liver transplantation in the most severely ill cirrhotic patients: A multicenter study in acute-on-chronic liver failure grade 3Florent Artru, Alexandre Louvet, Isaac Ruiz, et al.
Hepatology (Baltimore, Md.)|February 20, 2024
Serum aryl hydrocarbon receptor activity is associated with survival in patients with alcohol-associated hepatitisTomoo Yamazaki, Tetsuya Kouno, Cynthia L Hsu, et al.
Clinical and Molecular Hepatology|January 9, 2025
Global epidemiology of alcohol-related liver disease, liver cancer, and alcohol use disorder, 2000-2021Pojsakorn Danpanichkul, Luis Antonio Díaz, Kanokphong Suparan, et al.
Nature Communications|July 28, 2021
Super enhancer regulation of cytokine-induced chemokine production in alcoholic hepatitisMengfei Liu, Sheng Cao, Li He, et al.
JHEP Reports : Innovation in Hepatology|March 20, 2023
TACE and conformal radiotherapy <i>vs</i>. TACE alone for hepatocellular carcinoma: A randomised controlled trialCyrille Féray, Loic Campion, Philippe Mathurin, et al.
Journal of Hepatology|March 15, 2012
Rapid and strong antiviral activity of the non-nucleosidic NS5B polymerase inhibitor BI 207127 in combination with peginterferon alfa 2a and ribavirinDominique Larrey, Ansgar W Lohse, Victor de Ledinghen, et al.
Hepatology (Baltimore, Md.)|June 23, 2019
Intestinal Fungal Dysbiosis and Systemic Immune Response to Fungi in Patients With Alcoholic HepatitisSonja Lang, Yi Duan, Jinyuan Liu, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|August 28, 2013
Brivanib in patients with advanced hepatocellular carcinoma who were intolerant to sorafenib or for whom sorafenib failed: results from the randomized phase III BRISK-PS studyJosep M Llovet, Thomas Decaens, Jean-Luc Raoul, et al.
Pageof 29